Preclinical evaluation of the Versius surgical system: A next-generation surgical robot for use in minimal access prostate surgery.
cystectomy
minimal access surgery
prostatectomy
robot‐assisted surgery
urological surgical procedures
Journal
BJUI compass
ISSN: 2688-4526
Titre abrégé: BJUI Compass
Pays: United States
ID NLM: 101764975
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
12
12
2022
revised:
20
02
2023
accepted:
20
02
2023
medline:
19
6
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
epublish
Résumé
To evaluate the Versius surgical system for robot-assisted prostatectomy in a preclinical cadaveric model using varying system setups and collect surgeon feedback on the performance of the system and instruments, in line with IDEAL-D recommendations. Procedures were performed in cadaveric specimens by consultant urological surgeons to evaluate system performance in completing the surgical steps required for a prostatectomy. Procedures were conducted using either a 3-arm or 4-arm bedside unit (BSU) setup. Optimal port placements and BSU layouts were determined and surgeon feedback collected. Procedure success was defined as the satisfactory completion of all steps of the procedure, according to the operating surgeon. All four prostatectomies were successfully completed; two were completed with a 3-arm BSU setup and two using a 4-arm BSU setup. Small adjustments were made to the port and BSU positioning, according to surgeon preference, in order to complete the surgical steps. The surgeons noted some instrument difficulties with the Monopolar Curved Scissor tip and the Needle Holders, which were subsequently refined between the first and second sessions of the study, in line with surgeon feedback. Three cystectomies were also successfully completed, demonstrating the capability of the system to perform additional urological procedures. This study provides a preclinical assessment of a next-generation surgical robot for prostatectomies. All procedures were completed successfully, and port and BSU positions were validated, thus supporting the progression of the system to further clinical development according to the IDEAL-D framework.
Identifiants
pubmed: 37334028
doi: 10.1002/bco2.233
pii: BCO2233
pmc: PMC10268579
doi:
Types de publication
Journal Article
Langues
eng
Pagination
482-490Informations de copyright
© 2023 The Authors. BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU International Company.
Déclaration de conflit d'intérêts
Nikhil Vasdev: No conflicts of interest or financial ties to disclose. Philip Charlesworth: No conflicts of interest or financial ties to disclose. Mark Slack: Chief Medical Officer and Co‐founder of CMR Surgical. Jim Adshead: Member of the advisory board for Lightpoint Medical.
Références
Ann R Coll Surg Engl. 2020 Nov;102(9):717-725
pubmed: 32538121
J Minim Access Surg. 2017 Apr-Jun;13(2):124-130
pubmed: 28281476
Indian J Surg Oncol. 2012 Jun;3(2):77-84
pubmed: 23730094
Surg Clin North Am. 2020 Apr;100(2):461-468
pubmed: 32169190
Eur Urol Focus. 2021 Mar;7(2):444-452
pubmed: 32169362
Ann Surg. 2019 Feb;269(2):211-220
pubmed: 29697448
Eur Rev Med Pharmacol Sci. 2015 Feb;19(4):525-31
pubmed: 25753865
J Surg Oncol. 2015 Dec;112(7):746-52
pubmed: 26369794
BMJ Surg Interv Health Technol. 2019 Dec 02;1(1):e000019
pubmed: 35047780
Ann Surg. 2023 Jan 1;277(1):9-17
pubmed: 35170538
Comput Aided Surg. 2011;16(1):38-45
pubmed: 21198426
Urol Ann. 2011 Jan;3(1):1-7
pubmed: 21346825
Expert Rev Anticancer Ther. 2014 Nov;14(11):1317-21
pubmed: 25266367
Acta Obstet Gynecol Scand. 2022 Sep;101(9):978-986
pubmed: 35861102
BMJ Surg Interv Health Technol. 2021 Oct 18;3(1):e000057
pubmed: 35051252
Lancet. 2009 Sep 26;374(9695):1105-12
pubmed: 19782876
Surg Clin North Am. 2016 Jun;96(3):615-36
pubmed: 27261798
Cancer J. 2013 Mar-Apr;19(2):133-9
pubmed: 23528721
Surg Endosc. 2021 May;35(5):2169-2177
pubmed: 32405893
BMJ. 2016 Jun 09;353:i2372
pubmed: 27283585
J Turk Ger Gynecol Assoc. 2016 Dec 01;17(4):224-232
pubmed: 27990092
Eur J Cardiothorac Surg. 2022 Aug 3;62(3):
pubmed: 35413097
Rev Urol. 2010 Winter;12(1):35-43
pubmed: 20428292
Arch Esp Urol. 2011 Oct;64(8):823-9
pubmed: 22052763
BMJ Surg Interv Health Technol. 2020 May 22;2(1):e000028
pubmed: 35047788